Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: Acalabrutinib
Study Purpose: This study was done to learn more about how acalabrutinib acts in the blood in healthy participants when taken in different ways
Protocol Number: D8220C00018

Thank you!
Thank you for taking part in the clinical study for the study drug acalabrutinib. AstraZeneca sponsored this study and believes it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you.

If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.